MedPath

A clinical study to evaluate the efficacy of Akika Pishti with Jatamansyadi Kwath in the management of Raktagata Vata (Essential Hypertension)

Phase 2
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2024/07/069945
Lead Sponsor
Institute For Ayurved Studies and Reasearch
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.The patient presented with cardinal features of Raktagata vata or Rakta dushti janya vikaras as described in Ayurvedic texts.

2.Randomly selected irrespective of their caste, religion and sex.

3.Patient with the age group of Age of 18-45 years.

4.Patients with prehypertension and stage 1 hypertension.

5.Willing and able to participate in the study.

Exclusion Criteria

1.Patient below 18 years and above 45 years of age.

2.Patient with SBP =160 mmHg, DBP =100 mmHg.

3.Secondary Hypertension (Chronic kidney disease Hypothyroidism, Hyperthyroidism, Hyperaldosteronism, Uncontrolled diabetes mellitus).

4.The patient taking steroids, oral contraceptive pills and estrogen replacement therapy.

5.Patient having systemic/serious complication of Cardio-vascular/ Cerebro-vascular/ Renal system.

6.Patient having an illness such as Ischemic heart disease, Chronic renal failure etc.

7.Any type of malignancy

8.Alcoholics and any other drug abusers.

9.Pregnant and Lactating women.

10.Patient having a history of Hypersensitivity to the trial drug or any of its ingredients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath